Pharma BD Deal Intelligence
Mylan Inc. / Bioniche Pharma Holdings Limited
2010 · Acquisition/Merger · $550M · Complete
Announcement Sentiment
100
Strongly positive
Mylan to acquire Ireland-based Bioniche Pharma for $550M cash, immediate North American hospital injectables presence. Closed September 2010.
Did it work? Outcome assessment
Strategic verdict
Achieved Stated Rationale
Financial impact
Accretive
Pipeline outcome
Assets Advanced
Assessment window: 5yr post-close.
Key facts
- Announced Jul 14, 2010
- Closed Sep 02, 2010
- Deal value $550M
- Deal type Acquisition/Merger
- Therapeutic area Hospital injectables (oncology, anesthesia, urology)
- Indications Hospital injectables (oncology, anesthesia, urology)
- Key assets Generic injectable pharmaceuticals
- Mechanism Generic injectables platform
See the full interactive analysis, sources & comparables →
← Browse all deals ·
How we score deals